Catalyst Wire Dossier Catalyst Wire Dossier

OCTREOSCAN

Indium-111 pentetreotide · Curium US LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for OCTREOSCAN, covering 2016-09-09 to 2022-02-09. Get the full timeline:

Most recent: FDA Approved: OCTREOSCAN — Supplemental Application (Curium US LLC)

See pricing